Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Raw Materials (2016 - 2019)

Tandem Diabetes Care (TNDM) has disclosed Raw Materials for 6 consecutive years, with $9.6 million as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Raw Materials fell 7.79% year-over-year to $9.6 million, compared with a TTM value of $9.6 million through Mar 2019, down 7.79%, and an annual FY2018 reading of $6.6 million, down 35.88% over the prior year.
  • Raw Materials was $9.6 million for Q1 2019 at Tandem Diabetes Care, up from $6.6 million in the prior quarter.
  • Across five years, Raw Materials topped out at $12.1 million in Q2 2016 and bottomed at $6.6 million in Q4 2018.
  • Average Raw Materials over 5 years is $9.9 million, with a median of $10.0 million recorded in 2016.
  • The sharpest move saw Raw Materials surged 49.7% in 2015, then crashed 35.88% in 2018.
  • Year by year, Raw Materials stood at $10.6 million in 2015, then decreased by 11.61% to $9.4 million in 2016, then grew by 10.17% to $10.3 million in 2017, then plummeted by 35.88% to $6.6 million in 2018, then skyrocketed by 44.74% to $9.6 million in 2019.
  • Business Quant data shows Raw Materials for TNDM at $9.6 million in Q1 2019, $6.6 million in Q4 2018, and $8.6 million in Q3 2018.